RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss Lands End LE reports steep Q1 2026 EPS miss stock dips 179 amid ongoing profitability headwinds Replimune Group REPL Stock Market Pressure Analysis Smart Money Exits 20260427